A new study reveals a novel approach to mitigating tissue damage caused by Streptococcus pyogenes, the flesh-eating bacterium responsible for severe infections such as necrotizing fasciitis. The ...

A new study published in Nature Communications reveals a novel approach to mitigating tissue damage caused by Streptococcus ...

But the MRI uncovered a tumor, and subsequent mammograms and biopsies confirmed she had breast cancer. Researchers at ...

The way they did it was to design a custom, synthetic cannabinoid molecule that is positively charged, which prevents it from being able to cross the blood-brain barrier. This means it can’t bind to ...

A new study published in Nature Communications reveals a novel approach to mitigating tissue damage caused by Streptococcus pyogenes, the flesh-eating ...

Under federal law, device makers must submit adverse event reports they receive from patients to the FDA’s Manufacturer And User Facility Device Experience (MAUDE) database within 30 days, researchers ...

"A lot of people in medicine feel very threatened right now, and very apprehensive about what the future holds." -- Celeste ...

Reports on medical device adverse events widely exceed FDA deadlines, according to a recent study published in the BMJ. Read ...

Strong support from pharma groups including Amgen, Bristol Myers Squibb and Pfizer has allowed European venture capital firm Sofinnova Partners to close a new biotech fund with €165 million ($180 ...

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

The following students have been named to the dean’s list for the fall 2024 semester at Washington University in St.